renal anemia
Conditions
Interventions
Intervention type:
Name of intervention:
Dose form / Japanese Medical Device Nomenclature:
Route of administration / Site of application:
Dose per administration:
Dosing frequency / Frequency of use:
Sponsors
shogo kimura
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A common selection criteria) Patients - three times a week hemodialysis have received more than one year Patients obvious iron deficiency is not observed in-the past three months - 20 years of age or older patients Patients who obtained the consent, with respect to the present study (A group) DA was administered once a week Hb is 7.1 - 9.9g / dL and the effect inadequate for switching to CERA Patients were example Patient - DA dose per week of 10 - 60 (B group) Patients receiving CERA - twice a monthPatients and one month CERA dose per month of 50 -200 Patients - Hb concentration of the past three months has remained at 10 - 12g / dL
Exclusion criteria
Exclusion criteria: Patient management is insufficient -Hb concentration (Hb patients 13g / dL has been confirmed) Hypertensive patients poorly controlled with oral medicine,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hb,Frt,TSAT,Hep,MCV,at the start of ERI value at the end of ERI value | — |
Secondary
| Measure | Time frame |
|---|---|
| Target Hb retention rate | — |
Countries
Japan
Contacts
Public Contactshogo kimura
ryogoku ekimae dialysis clinic
Outcome results
None listed